Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report.
Journal: International journal of molecular sciences
Published: December 26, 2022
Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR).
Journal: International journal of molecular sciences
Published: November 23, 2022
Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib.
Journal: Biomedicines
Published: August 28, 2022
Disparities in Metabolic Conditions and Cancer Characteristics among Hispanic Women with Breast Cancer: A Multi-Institutional Study.
Journal: Cancers
Published: June 08, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy.
Journal: JCO precision oncology
Published: June 06, 2022
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis.
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis.
Journal: Scientific reports
Published: March 11, 2022
Precision Medicine Targeting FGFR2 Genomic Alterations in Advanced Cholangiocarcinoma: Current State and Future Perspectives.
Journal: Frontiers in oncology
Published: January 23, 2022
Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study.
Journal: Digestive diseases and sciences
Published: September 14, 2021
Infigratinib (BGJ398): an investigational agent for the treatment of FGFR-altered intrahepatic cholangiocarcinoma.
Journal: Expert opinion on investigational drugs
Published: December 14, 2020
Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.
Journal: The oncologist
Published: August 31, 2020
Last Updated: 09/26/2026